Drug intelligence / Profile preview

mcRM153

Development stage
Preclinical
Lead developer
Epitope Science
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intperitoneal, Intravenous, Subcutaneous
01

Overview

mcRM153 is a mouse chimeric recombinant antibody (rat-mouse chimeric antibody) engineered with antibody-dependent cellular cytotoxicity (ADCC) activity. It is derived from the variable domain of the commercially available rat-derived anti-mouse CD153 antibody (clone RM153). Developed by Kyoto University and Epitope Science, mcRM153 targets CD153 (CD30 ligand), which is expressed on senescence-associated T cells (SA-T cells). By targeting CD153, the antibody depletes SA-T cells, suppresses tertiary lymphoid structure (TLS) formation, and reduces fibrosis and failed-repair proximal tubules in aged injured kidneys. It is being investigated in preclinical models for the treatment of chronic kidney disease (CKD).

Other names
mouse chimeric recombinant antibody mcRM153rat-mouse chimeric anti-CD153 antibody
02

Targets

TNFSF8 (CD30 ligand)

Beyond the preview

Go deeper on mcRM153.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mcRM153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call